PMID: 7028845Nov 1, 1981Paper

Adverse drug reactions among the elderly: a reassessment

Journal of the American Geriatrics Society
L E KleinD M Levine

Abstract

The elderly are widely believed to be predisposed to adverse drug reactions, chiefly because of the large quantities of drugs they consume, combined with the effects of aging on distribution, metabolism, and the patterns of drug usage. These beliefs affect the physician's prescribing behavior. To study the validity of these concepts, the supporting medical literature was reviewed. Existing studies of the rates of adverse drug reactions have several methodologic limitations, including inadequate control for disease severity, the use of calculation denominators which overestimate incidence, and dependence upon definitions of medication error rates which do not adequately reflect the potential for adverse outcome. Further studies are needed for clarification of drug-use patterns and problems among the elderly.

References

Dec 18, 1976·Lancet·G JacksonJ Condon
May 1, 1979·Postgraduate Medicine·F A Finnerty
Nov 2, 1979·JAMA : the Journal of the American Medical Association·J M LeventhalA R Feinstein
Apr 1, 1978·Clinical Pharmacology and Therapeutics·M M ReidenbergJ Cheripko
Nov 1, 1978·British Journal of Clinical Pharmacology·B CusackK O'Malley
Jan 3, 1977·European Journal of Clinical Pharmacology·J Koch-WeserR Zacest
May 1, 1977·The Medical Clinics of North America·A R DyerE Farinaro
Apr 1, 1976·British Journal of Clinical Pharmacology·S Wallace, B Whiting
Sep 18, 1976·British Medical Journal·D M ParkinJ Crooks
Jan 1, 1976·Hospital Practice·P P Lamy, R Vestal
Feb 1, 1975·The Journal of Clinical Investigation·U KlotzG R Wilkinson
Oct 1, 1975·Clinical Pharmacology and Therapeutics·R E VestalR Andres
Sep 1, 1975·Journal of Gerontology·D M Petersen, C W Thomas
Mar 6, 1976·British Medical Journal·R Law, C Chalmers
May 1, 1976·Clinical Pharmacology and Therapeutics·F E KarchL Lasagna
Jan 1, 1974·Drugs·G E Bauer
May 6, 1974·JAMA : the Journal of the American Medical Association·G J CaranasosL E Cluff
Jun 1, 1969·American Journal of Surgery·M C Geokas, B J Haverback
Nov 1, 1972·Clinical Pharmacology and Therapeutics·B Blackwell
Nov 1, 1972·Clinical Science·T G PickeringD O Oliver
Aug 22, 1970·British Medical Journal·D A ChamberlainT W Smith
Sep 1, 1970·Metabolism: Clinical and Experimental·G B Forbes, J C Reina
Mar 1, 1969·British Medical Journal·N Hurwitz
Apr 1, 1969·Circulation·G A EwyF I Marcus
Jun 19, 1980·The New England Journal of Medicine·J Koch-WeserE O'Brien
Aug 1, 1959·The American Journal of Medicine·I S EDELMAN, J LEIBMAN
Dec 1, 1962·American Journal of Public Health and the Nation's Health·D SCHWARTZM E GOSS
Jan 1, 1964·Annals of Internal Medicine·E M SCHIMMEL
Oct 15, 1964·The New England Journal of Medicine·O APPENZELLER, L DESCARRIES

❮ Previous
Next ❯

Citations

Jun 28, 2011·Pharmacoepidemiology and Drug Safety·Francisca González-RubioAlexandra Prados-Torres
Aug 1, 1990·Archives of Psychiatric Nursing·I L AbrahamH R Brashear
Jan 1, 1988·Journal of the American Geriatrics Society·R J Michocki, P P Lamy
Feb 1, 1988·Journal of the American Geriatrics Society·L Nolan, K O'Malley
Dec 1, 1988·Journal of the American Geriatrics Society·R E GrymonpreP R Montgomery
Jun 1, 1982·Journal of the American Geriatrics Society·D JahnigenF M LaForce
Sep 1, 1982·Journal of the American Geriatrics Society·P S GermanC R Smith
Jun 1, 1987·Journal of the American Geriatrics Society·E GranekL E Klein
Mar 15, 2015·Journal of Basic and Clinical Pharmacy·Aaseer Thamby SamSubramani Parasuraman
Apr 26, 2016·Journal of Pharmacological and Toxicological Methods·M I GeerM Y Shah
Sep 4, 1999·Journal of Clinical Pharmacy and Therapeutics·J F ReeveR Jaffrey
Apr 1, 1990·Journal of Clinical Pharmacy and Therapeutics·C A Haffner, A Main
Jan 9, 1989·Journal of Aging and Health·P S German, L C Burton
Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R E Vestal
Mar 1, 1988·Hypertension·L E Klein
Aug 3, 1989·The New England Journal of Medicine·S C MontamatR E Vestal

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Harvard Review of Psychiatry
C Salzman, L Tune
Archives of Internal Medicine
Jane McCuskerEric Belzile
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Anne W S RutjesPatrick M M Bossuyt
© 2021 Meta ULC. All rights reserved